002437 誉衡药业
交易中 08-13 10:43:15
资讯
新帖
简况
8月12日誉衡药业（002437）龙虎榜数据：机构净买入875.12万元，北向资金净卖出2293.76万元
证券之星 · 08-12 17:31
8月12日誉衡药业（002437）龙虎榜数据：机构净买入875.12万元，北向资金净卖出2293.76万元
8月12日誉衡药业创60日新高，中证2000ETF广发基金重仓该股
证券之星 · 08-12 16:34
8月12日誉衡药业创60日新高，中证2000ETF广发基金重仓该股
异动快报：誉衡药业（002437）8月12日9点39分触及涨停板
证券之星 · 08-12 09:40
异动快报：誉衡药业（002437）8月12日9点39分触及涨停板
8月10日誉衡药业创60日新高，中证2000ETF广发基金重仓该股
证券之星 · 08-10 16:47
8月10日誉衡药业创60日新高，中证2000ETF广发基金重仓该股
异动快报：誉衡药业（002437）8月10日9点33分触及涨停板
证券之星 · 08-10
异动快报：誉衡药业（002437）8月10日9点33分触及涨停板
誉衡药业：安脑丸/片的销量与天气没有直接关系
证券之星 · 08-06
誉衡药业：安脑丸/片的销量与天气没有直接关系
誉衡药业：截止到2026年7月31日，公司股东人数为9.22万户
证券之星 · 08-03
誉衡药业：截止到2026年7月31日，公司股东人数为9.22万户
股市必读：7月29日誉衡药业现2259.4万元大宗交易
证券之星 · 07-30
股市必读：7月29日誉衡药业现2259.4万元大宗交易
7月27日誉衡药业涨5.07%，中证2000ETF广发基金重仓该股
证券之星 · 07-27
7月27日誉衡药业涨5.07%，中证2000ETF广发基金重仓该股
异动快报：誉衡药业（002437）6月29日10点59分触及涨停板
证券之星 · 06-29
异动快报：誉衡药业（002437）6月29日10点59分触及涨停板
誉衡药业：截止到2026年6月20日，公司股东人数为9.13万户
证券之星 · 06-24
誉衡药业：截止到2026年6月20日，公司股东人数为9.13万户
誉衡药业：截止到2026年5月29日，公司股东人数为9.32万户
证券之星 · 06-05
誉衡药业：截止到2026年5月29日，公司股东人数为9.32万户
誉衡药业：公司自有产品西格列汀二甲双胍缓释片为治疗2型糖尿病的药品
证券之星 · 06-04
誉衡药业：公司自有产品西格列汀二甲双胍缓释片为治疗2型糖尿病的药品
誉衡药业：截止到2026年5月20日，公司股东人数为9.44万户
证券之星 · 06-04
誉衡药业：截止到2026年5月20日，公司股东人数为9.44万户
誉衡药业(002437)5月20日股东户数9.44万户，较上期增加1.29%
证券之星 · 06-01
誉衡药业(002437)5月20日股东户数9.44万户，较上期增加1.29%
誉衡药业：截止到2026年5月20日，公司股东人数为9.44万户
证券之星 · 05-21
誉衡药业：截止到2026年5月20日，公司股东人数为9.44万户
誉衡药业：公司将持续通过夯实主营业务、加强精细化管理等方式努力做好业绩
证券之星 · 05-19
誉衡药业：公司将持续通过夯实主营业务、加强精细化管理等方式努力做好业绩
誉衡药业：公司已完成内部组织架构的调整及精简
证券之星 · 05-19
誉衡药业：公司已完成内部组织架构的调整及精简
誉衡药业：公司与第一三共终止产品推广合作
证券之星 · 05-19
誉衡药业：公司与第一三共终止产品推广合作
誉衡药业（002437）披露关于使用公积金弥补亏损通知债权人的公告，5月18日股价上涨0.32%
证券之星 · 05-18
誉衡药业（002437）披露关于使用公积金弥补亏损通知债权人的公告，5月18日股价上涨0.32%
暂无数据
公司概况
公司名称：
哈尔滨誉衡药业股份有限公司
所属行业：
医药制造业
上市日期：
2010-06-23
主营业务：
哈尔滨誉衡药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是维生素类药物、心脑血管药物、骨科药物、电解质类药物、抗肿瘤药物、抗感染药物、其他用药领域、糖尿病类药物、镇痛类药物。
发行价格：
50.00
{"stockData":{"symbol":"002437","market":"SZ","secType":"STK","nameCN":"誉衡药业","latestPrice":4.25,"timestamp":1786588995000,"preClose":3.86,"halted":0,"volume":443588719,"delay":0,"changeRate":0.101,"floatShares":2100000000,"shares":2230000000,"eps":0.1846,"marketStatus":"交易中","change":0.39,"latestTime":"08-13 10:43:15","open":3.73,"high":4.25,"low":3.69,"amount":1796000000,"amplitude":0.1451,"askPrice":0,"askSize":0,"bidPrice":4.25,"bidSize":418138,"shortable":0,"etf":0,"ttmEps":0.1846,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786591800000},"marketStatusCode":2,"adr":0,"adjPreClose":3.86,"symbolType":"stock","openAndCloseTimeList":[[1786584600000,1786591800000],[1786597200000,1786604400000]],"highLimit":4.25,"lowLimit":3.47,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2229868126,"isCdr":false,"pbRate":3.6,"roa":"--","peRate":23.022752,"roe":"4.05%","epsLYR":0.1719,"committee":0,"marketValue":9477000000,"turnoverRate":0.2112,"status":0,"floatMarketCap":8926000000},"requestUrl":"/m/hq/s/002437/tweets","defaultTab":"tweets","newsList":[{"id":"2658293973","title":"8月12日誉衡药业（002437）龙虎榜数据：机构净买入875.12万元，北向资金净卖出2293.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658293973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658293973?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:31","pubTimestamp":1786527115,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月12日公布的交易公开信息显示，誉衡药业因日涨幅偏离值达到7%的前5只证券，日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年8月12日收盘，誉衡药业报收于3.86元，上涨9.97%，涨停，换手率25.63%，成交量538.25万手，成交额20.41亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入875.12万元，北向资金合计净卖出2293.76万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200029892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002437","BK0188","BK0239","BK0095","BK0060","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658699920","title":"8月12日誉衡药业创60日新高，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658699920","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658699920?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:34","pubTimestamp":1786523658,"startTime":"0","endTime":"0","summary":"证券之星消息，8月12日誉衡药业涨9.97%创60日新高，收盘报3.86元，换手率25.63%，成交量538.25万手，成交额20.41亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200027663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0060","560220","002437","BK0095","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658479159","title":"异动快报：誉衡药业（002437）8月12日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2658479159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658479159?lang=zh_cn&edition=full","pubTime":"2026-08-12 09:40","pubTimestamp":1786498841,"startTime":"0","endTime":"0","summary":"证券之星8月12日盘中消息，9点39分誉衡药业（002437）触及涨停板。其所属行业化学制药目前上涨。领涨股为誉衡药业。该股为PD-1抑制剂，民营医院，化学原料药概念热股，当日PD-1抑制剂概念上涨1.7%，民营医院概念上涨0.98%，化学原料药概念上涨0.66%。8月11日的资金流向数据方面，主力资金净流入8659.32万元，占总成交额4.08%，游资资金净流出1.01亿元，占总成交额4.76%，散户资金净流入1449.6万元，占总成交额0.68%。近5日资金流向一览见下表：誉衡药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200009600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0188","BK0060","BK0239","BK0028","BK0095","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658813719","title":"8月10日誉衡药业创60日新高，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658813719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658813719?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:47","pubTimestamp":1786351664,"startTime":"0","endTime":"0","summary":"证券之星消息，8月10日誉衡药业涨9.94%创60日新高，收盘报3.43元，换手率21.97%，成交量461.49万手，成交额15.68亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000020986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0095","BK0188","BK0028","002437","BK0060","560220"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609526","title":"异动快报：誉衡药业（002437）8月10日9点33分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658609526?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:36","pubTimestamp":1786325778,"startTime":"0","endTime":"0","summary":"证券之星8月10日盘中消息，9点33分誉衡药业（002437）触及涨停板。其所属行业化学制药目前上涨。领涨股为贝达药业。该股为医药，化学原料药，PD-1抑制剂概念热股，当日医药概念上涨1.41%，化学原料药概念上涨1.38%，PD-1抑制剂概念上涨1.33%。8月7日的资金流向数据方面，主力资金净流入2.06亿元，占总成交额29.21%，游资资金净流出9454.54万元，占总成交额13.43%，散户资金净流出1.11亿元，占总成交额15.77%。近5日资金流向一览见下表：誉衡药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000003357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0060","002437","BK0095","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657168393","title":"誉衡药业：安脑丸/片的销量与天气没有直接关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2657168393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657168393?lang=zh_cn&edition=full","pubTime":"2026-08-06 15:36","pubTimestamp":1786001766,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！天气炎热，最近公司独家药品安脑丸终端销售怎么样？最近是否因为天气原因安脑丸开单走量增多？请说一下！誉衡药业回复：您好，公司安脑丸/片的销量与天气没有直接关系，具体销售情况请您参考公司后续披露的2026年半年度报告，谢谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600020790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0028","BK0188","BK0060","BK0239","BK0095","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656532192","title":"誉衡药业：截止到2026年7月31日，公司股东人数为9.22万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2656532192","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656532192?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:15","pubTimestamp":1785744915,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)08月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止7月31日股东人数是多少？誉衡药业回复：您好，截止到2026年7月31日，公司股东人数为9.22万户，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300019607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0077","BK0188","BK0028","BK0095","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655890805","title":"股市必读：7月29日誉衡药业现2259.4万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2655890805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655890805?lang=zh_cn&edition=full","pubTime":"2026-07-30 01:30","pubTimestamp":1785346232,"startTime":"0","endTime":"0","summary":"截至2026年7月29日收盘，誉衡药业报收于2.88元，上涨0.0%，换手率3.06%，成交量64.28万手，成交额1.85亿元。当日关注点交易信息汇总：7月29日誉衡药业发生2259.4万元大宗交易。交易信息汇总资金流向7月29日主力资金净流出428.57万元，占总成交额0.0%；游资资金净流出564.1万元，占总成交额0.0%；散户资金净流入992.67万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000000820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0077","BK0095","BK0188","BK0028","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654013126","title":"7月27日誉衡药业涨5.07%，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654013126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654013126?lang=zh_cn&edition=full","pubTime":"2026-07-27 16:46","pubTimestamp":1785141987,"startTime":"0","endTime":"0","summary":"证券之星消息，7月27日誉衡药业涨5.07%，收盘报2.9元，换手率3.59%，成交量75.49万手，成交额2.16亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发目前规模为0.76亿元，最新净值1.2622，较上一交易日下跌2.71%，近一年下跌0.02%。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700021083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["560220","BK0060","BK0028","002437","BK0095","BK0239","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647347120","title":"异动快报：誉衡药业（002437）6月29日10点59分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647347120","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647347120?lang=zh_cn&edition=full","pubTime":"2026-06-29 11:00","pubTimestamp":1782702055,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，10点59分誉衡药业（002437）触及涨停板。其所属行业化学制药目前上涨。领涨股为广生堂。该股为PD-1抑制剂，医药，化学原料药概念热股，当日PD-1抑制剂概念上涨7.01%，医药概念上涨4.44%，化学原料药概念上涨4.33%。6月26日的资金流向数据方面，主力资金净流出2438.5万元，占总成交额14.08%，游资资金净流入1022.07万元，占总成交额5.9%，散户资金净流入1416.43万元，占总成交额8.18%。近5日资金流向一览见下表：誉衡药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900010682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","BK0028","BK0060","BK0095","002437"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645869525","title":"誉衡药业：截止到2026年6月20日，公司股东人数为9.13万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645869525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645869525?lang=zh_cn&edition=full","pubTime":"2026-06-24 11:37","pubTimestamp":1782272228,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年6月20日公司的股东总数是多少？谢谢誉衡药业回复：您好，截止到2026年6月20日，公司股东人数为9.13万户，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400018325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0060","002437","BK0239","BK0095","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641118845","title":"誉衡药业：截止到2026年5月29日，公司股东人数为9.32万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2641118845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641118845?lang=zh_cn&edition=full","pubTime":"2026-06-05 15:06","pubTimestamp":1780643177,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问：单边下跌这么久，请问截止6月3日，公司股东有多少名？誉衡药业回复：您好，公司不掌握实时股东人数。截止到2026年5月29日，公司股东人数为9.32万户，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500020375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002437","BK0028","BK0239","BK0188","BK0060","BK0095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640339441","title":"誉衡药业：公司自有产品西格列汀二甲双胍缓释片为治疗2型糖尿病的药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2640339441","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640339441?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:12","pubTimestamp":1780535530,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：本月是糖尿病学界的“黄金月”，全球最高规格的ADA年会与国内中青年医师论坛密集召开。公司有治疗糖尿病方面的药品吗？誉衡药业回复：您好，公司自有产品西格列汀二甲双胍缓释片为治疗2型糖尿病的药品，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400005492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0028","BK0239","BK0060","BK0077","BK0095","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640133943","title":"誉衡药业：截止到2026年5月20日，公司股东人数为9.44万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2640133943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640133943?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:12","pubTimestamp":1780535528,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截至2026年5月20日股东数是多少？谢谢。誉衡药业回复：您好，截止到2026年5月20日，公司股东人数为9.44万户，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400005486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0077","BK0188","BK0028","BK0095","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640293018","title":"誉衡药业(002437)5月20日股东户数9.44万户，较上期增加1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640293018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640293018?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:43","pubTimestamp":1780306987,"startTime":"0","endTime":"0","summary":"证券之星消息，近日誉衡药业披露，截至2026年5月20日公司股东户数为9.44万户，较5月10日增加1200.0户，增幅为1.29%。在化学制药行业个股中，誉衡药业股东户数高于行业平均水平，截至5月20日，化学制药行业平均股东户数为3.56万户。从股价来看，2026年5月10日至2026年5月20日，誉衡药业区间跌幅为5.42%，在此期间股东户数增加1200.0户，增幅为1.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100027053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0077","BK0239","002437","BK0028","BK0188","BK0095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637880525","title":"誉衡药业：截止到2026年5月20日，公司股东人数为9.44万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2637880525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637880525?lang=zh_cn&edition=full","pubTime":"2026-05-21 11:34","pubTimestamp":1779334482,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)05月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到5月19日，贵司股东有多少名？誉衡药业回复：您好，截止到2026年5月20日，公司股东人数为9.44万户，感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100018830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0077","BK0239","BK0028","BK0095","002437"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636883324","title":"誉衡药业：公司将持续通过夯实主营业务、加强精细化管理等方式努力做好业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2636883324","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636883324?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:12","pubTimestamp":1779153129,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：公司2025年年报致股东信中提到“公司加权平均净资产收益率提升至18%，盈利质量持续显著提升”。请问公司如何看待ROE指标，对2026年以及将来有什么展望？誉衡药业回复：您好，近三年来，公司在资产质量、盈利能力、运营效率等方面取得了有效的改善和提升，后续，公司将持续通过夯实主营业务、加强精细化管理等方式努力做好业绩。谢谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900010213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0077","BK0188","BK0028","BK0095","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636838268","title":"誉衡药业：公司已完成内部组织架构的调整及精简","url":"https://stock-news.laohu8.com/highlight/detail?id=2636838268","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636838268?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:12","pubTimestamp":1779153129,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请介绍一下公司2026年的营销改革，目前在终端覆盖与渗透率方面有何进展？谢谢誉衡药业回复：您好，公司积极推进营销改革工作，截至目前，公司已完成内部组织架构的调整及精简，并加大精细化管理力度。公司主要产品的市场覆盖情况请您参考公司2025年年度报告“第三节 管理层讨论与分析”中“公司及主要产品的行业地位”，谢谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900010212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0095","BK0060","BK0188","002437","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636838208","title":"誉衡药业：公司与第一三共终止产品推广合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2636838208","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636838208?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:12","pubTimestamp":1779153126,"startTime":"0","endTime":"0","summary":"谢谢誉衡药业回复：您好。2、剔除与第一三共终止合作这个因素，公司2026年一季度整体收入有7%以上的增长，具体详见4月28日披露的《誉衡药业：002437誉衡药业投资者关系管理信息20260428》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900010210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0077","BK0239","BK0028","BK0095","002437"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636074451","title":"誉衡药业（002437）披露关于使用公积金弥补亏损通知债权人的公告，5月18日股价上涨0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636074451","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636074451?lang=zh_cn&edition=full","pubTime":"2026-05-18 22:38","pubTimestamp":1779115096,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，誉衡药业报收于3.16元，较前一交易日上涨0.32%，最新总市值为70.46亿元。近日，哈尔滨誉衡药业股份有限公司披露《关于使用公积金弥补亏损通知债权人的公告》。根据相关规定，公司需通知债权人，债权人自接到通知之日起30日内或未接到通知的自公告披露之日起45日内，可要求公司清偿债务或提供担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800037817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0077","BK0095","BK0188","BK0028","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786588996795,"stockEarnings":[{"period":"1week","weight":0.3219},{"period":"1month","weight":0.2781},{"period":"3month","weight":0.2025},{"period":"6month","weight":0.1592},{"period":"1year","weight":0.0604},{"period":"ytd","weight":0.2573}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"哈尔滨誉衡药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"92200人(较上一季度增加0.99%)","perCapita":"22778股","listingDate":"2010-06-23","address":"黑龙江省哈尔滨市呼兰区利民经济技术开发区北京路29号","registeredCapital":"222986万元","survey":" 哈尔滨誉衡药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是维生素类药物、心脑血管药物、骨科药物、电解质类药物、抗肿瘤药物、抗感染药物、其他用药领域、糖尿病类药物、镇痛类药物。","listedPrice":50},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"誉衡药业(002437)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供誉衡药业(002437)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"誉衡药业,002437,誉衡药业股票,誉衡药业股票老虎,誉衡药业股票老虎国际,誉衡药业行情,誉衡药业股票行情,誉衡药业股价,誉衡药业股市,誉衡药业股票价格,誉衡药业股票交易,誉衡药业股票购买,誉衡药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"誉衡药业(002437)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供誉衡药业(002437)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}